Moore Capital Management »

Cerevel Therapeutics Hldng I shares owned by Moore Capital Management

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Moore Capital Management from 13F filings

Historical chart of Moore Capital Management investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Moore Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Moore Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.7M 43k 40.89
2023-12-31 $424k 10k 42.40

More positions owned by Moore Capital Management

Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Amazon (AMZN)
Ally Financial (ALLY)
Capital One Financial (COF)
Digital Realty Trust (DLR)
Ishares Tr Russell 2000 Etf (IWM)
Comerica Incorporated (CMA)
Ge Vernova (GEV)
Apple (AAPL)
Adobe Systems Incorporated (ADBE)
Carvana Cl A (CVNA)
Tesla Motors (TSLA)
Discover Financial Services (DFS)
Select Sector Spdr Tr Energy (XLE)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)

View all positions for Moore Capital Management

Top funds holding Cerevel Therapeutics Hldng I

Bain Capital Investors
Vanguard Group
BlackRock
State Street Corporation
Alliancebernstein
Qube Research & Technologies
Farallon Capital Management
Melqart Asset Management
Goldman Sachs Group
P. Schoenfeld Asset Management
Water Island Capital
Squarepoint Ops
Balyasny Asset Management
Hsbc Holdings
Morgan Stanley

View all funds holding Cerevel Therapeutics Hldng I